Legal

Eli Lilly interview: Innovation and compliance, active ingredients


Legislation roundup: Interbank bond trading, Shanghai property and art dealing


In the news: NPC takeaways, investors warn of VC dangers, China adjusts taxes for foreign e-commerce sites and pharma firms get hit where it hurts


In the news: Guangdong factories face an uncertain future, a Chinese company in the U.S. deals with cultural differences and ChemChina offers $43 billion to buy Syngenta